Search results for "SynKIR-310"

HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data

HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical trial for SynKIR-310—a...